Leung Joseph C K, Tang Sydney C W, Chan Loretta Y Y, Tsang Anita W L, Lan Hui Yao, Lai Kar Neng
Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong.
Nephrol Dial Transplant. 2003 Jan;18(1):36-45. doi: 10.1093/ndt/18.1.36.
It has been suggested that polymeric IgA (pIgA) or IgA immune complexes play a significant pathogenic role in IgA nephropathy (IgAN). Macrophage migration inhibitory factor (MIF) shares many activities with other pro-inflammatory cytokines. In human glomerulonephritis, including IgAN, glomerular expression of MIF is found to correlate with progressive renal injury. We hypothesized that deposition of pIgA within the kidney may lead to enhanced synthesis of MIF by mesangial cells.
In this study we examined the effect of pIgA and monomeric IgA (mIgA) from randomly selected patients with IgAN in clinical quiescence on the gene expression and protein synthesis of MIF in cultured human mesangial cells (HMC).
Both pIgA and mIgA from IgAN patients or matched healthy controls increased MIF gene expression and protein synthesis in a dose-dependent fashion. The magnitude of MIF protein induction by pIgA (100 microg/ml) was similar to that of tumour necrosis factor-alpha (TNF-alpha) at 10 pg/ml. In all subjects, the induction of MIF was higher for pIgA when compared with mIgA (P < 0.01). Furthermore, the up-regulation of MIF synthesis by either pIgA or mIgA was significantly higher in IgAN patients than in healthy controls (P < 0.05). Similarly, pIgA and mIgA were able to induce TNF-alpha gene expression and protein synthesis in mesangial cells. Incubation of mesangial cells with neutralizing antibody to TNF-alpha reduced the MIF synthesis induced by pIgA.
We demonstrate that pIgA is capable of inducing MIF and TNF-alpha production in HMC, which may play a major pathogenic role in IgAN. Induction of MIF can be partially blocked by neutralizing antibody to TNF-alpha, suggesting the possibility that up-regulation of MIF synthesis in HMC is mediated via an amplifying proinflammatory loop involving TNF-alpha.
有人提出,聚合性IgA(pIgA)或IgA免疫复合物在IgA肾病(IgAN)中发挥重要的致病作用。巨噬细胞移动抑制因子(MIF)与其他促炎细胞因子具有许多共同活性。在包括IgAN在内的人类肾小球肾炎中,发现MIF的肾小球表达与进行性肾损伤相关。我们推测,肾脏内pIgA的沉积可能导致系膜细胞合成MIF增加。
在本研究中,我们检测了临床静止期随机选取的IgAN患者的pIgA和单体IgA(mIgA)对培养的人系膜细胞(HMC)中MIF基因表达和蛋白质合成的影响。
IgAN患者或匹配的健康对照的pIgA和mIgA均以剂量依赖性方式增加MIF基因表达和蛋白质合成。pIgA(100μg/ml)诱导MIF蛋白的程度与10 pg/ml的肿瘤坏死因子-α(TNF-α)相似。在所有受试者中,与mIgA相比,pIgA诱导的MIF更高(P<0.01)。此外,IgAN患者中pIgA或mIgA对MIF合成的上调显著高于健康对照(P<0.05)。同样,pIgA和mIgA能够诱导系膜细胞中TNF-α基因表达和蛋白质合成。用抗TNF-α中和抗体孵育系膜细胞可降低pIgA诱导的MIF合成。
我们证明pIgA能够诱导HMC中MIF和TNF-α的产生,这可能在IgAN中起主要致病作用。抗TNF-α中和抗体可部分阻断MIF的诱导,提示HMC中MIF合成上调可能通过涉及TNF-α的放大促炎环路介导。